Author

Brian E Krumm

University of North Carolina at Chapel Hill

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:statistical model· 1

Frequent Co-Authors

Bryan L. RothiD· 1 shared Madigan L. BedardiD· 1 shared Xi-Ping HuangiD· 1 shared Zoé A. McElligottiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

4 top collaborators · 6 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperNeuroscience

Bryan L. RothORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Xylazine's k-opioid agonist activity is not shared with other FDA-approved alpha2-adrenergic agonists

Xi-Ping Huang, Brian E Krumm, Madigan L. Bedard, Zoé A. McElligott, Bryan L. Roth

The paper investigates whether other FDA-approved alpha2-adrenergic agonists share xylazine's kappa opioid agonist activity and finds they do not, but have distinct GPCR activity patterns.

bioRxiv · Mar 7, 2026 · PreprintNeuroscience